To examine the effect of the combined drug treatment in the ALS murine model SOD1(G93A), the clinical onset of the disease, as well as the life span were monitored in both the TREATED and VEH groups of the combined sexes, male and female mice. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.